Additionally, we saw significant decreases in CD71+CD235a+ and CD71–CD235a+ erythroid progenitors (Figure 1C) and in CD41–CD42+ megakaryocytes (Figure 1D) in patients with DBA versus HDs. This evidence concerns the gene TFRC and Diamond-Blackfan anemia.